| Year |
Citation |
Score |
| 2021 |
Snarski P, Sukhanov S, Yoshida T, Higashi Y, Danchuk S, Chandrasekar B, Tian D, Rivera-Lopez V, Delafontaine P. Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA121316090. PMID 34852642 DOI: 10.1161/ATVBAHA.121.316090 |
0.438 |
|
| 2019 |
Higashi Y, Gautam S, Delafontaine P, Sukhanov S. IGF-1 and cardiovascular disease. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 45: 6-16. PMID 30735831 DOI: 10.1016/j.ghir.2019.01.002 |
0.353 |
|
| 2017 |
Hou X, Snarski P, Higashi Y, Yoshida T, Jurkevich A, Delafontaine P, Sukhanov S. Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28404743 DOI: 10.1096/Fj.201601082R |
0.396 |
|
| 2014 |
Xing SS, Shen CC, Godard MP, Wang JJ, Yue YY, Yang ST, Zhao Q, Zhang SB, Wang TX, Yang XL, Delafontaine P, He Y, Song YH. Bortezomib inhibits C2C12 growth by inducing cell cycle arrest and apoptosis. Biochemical and Biophysical Research Communications. 445: 375-80. PMID 24525132 DOI: 10.1016/J.Bbrc.2014.02.008 |
0.39 |
|
| 2014 |
Sukhanov S, Yoshida T, Delafontaine P. GAPDH prevents oxidant-induced apoptosis in smooth muscle cells via upregulation of APE1/Ref-1 endonuclease (1093.1) The Faseb Journal. 28. DOI: 10.1096/Fasebj.28.1_Supplement.1093.1 |
0.472 |
|
| 2012 |
Delafontaine P, Brink M, Du J. Angiotensin II Modulation of Insulin-like Growth Factor I Expression in the Cardiovascular System. Trends in Cardiovascular Medicine. 6: 187-93. PMID 21232295 DOI: 10.1016/S1050-1738(96)00058-8 |
0.479 |
|
| 2011 |
Sukhanov S, Higashi Y, Shai SY, Blackstock C, Galvez S, Vaughn C, Titterington J, Delafontaine P. Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects. Febs Letters. 585: 3065-72. PMID 21872589 DOI: 10.1016/J.Febslet.2011.08.029 |
0.759 |
|
| 2011 |
Sukhanov S, Semrpun-Prieto L, Yoshida T, Atteia B, Gonzalez-Villalobos R, Vaughn C, Tabony M, Delafontaine P. ANOREXIGENIC AND CATABOLIC EFFECTS OF ANGIOTENSIN II ARE REDOX DEPENDENT: POTENTIAL MECHANISM OF CONGESTIVE HEART FAILURE-ASSOCIATED SKELETAL MUSCLE WASTING Journal of the American College of Cardiology. 57: E366. DOI: 10.1016/S0735-1097(11)60366-5 |
0.358 |
|
| 2009 |
Titterington JS, Sukhanov S, Higashi Y, Vaughn C, Bowers C, Delafontaine P. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. Endocrinology. 150: 5478-87. PMID 19819949 DOI: 10.1210/En.2009-0283 |
0.767 |
|
| 2007 |
Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 2684-90. PMID 17916769 DOI: 10.1161/Atvbaha.107.156257 |
0.767 |
|
| 2007 |
Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochemical and Biophysical Research Communications. 354: 700-6. PMID 17257581 DOI: 10.1016/J.Bbrc.2007.01.045 |
0.321 |
|
| 2007 |
Mourkioti F, Kratsios P, Luedde T, Song YH, Delafontaine P, Adami R, Parente V, Bottinelli R, Pasparakis M, Rosenthal N. Erratum: Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration (Journal of Clinical Investigation (2006) 116 (2945-2954) DOI:10.1172/JCI28721) Journal of Clinical Investigation. 117. DOI: 10.1172/Jci28721E1 |
0.308 |
|
| 2007 |
Semprun-Prieto L, Sukhanov S, Higashi Y, Titterington J, Delafontaine P. Identification Of 5-, 12/15-Lipoxygenase And Nadph Oxidase As Key Mediators Of Oxidized Low Density Lipoprotein-Induced Apoptosis Of Human Aortic Smooth Muscle Cells: Implications For Atherosclerotic Plaque Destabilization.: 277 Journal of Investigative Medicine. 55. DOI: 10.1097/00042871-200701010-00791 |
0.734 |
|
| 2007 |
Sukhanov S, Semprun-Prieto L, Huang J, Akao M, Delafontaine P. Increased Oxidative Stress via Activation of Nadph Oxidase Mediates Angiotensin Ii-Induced Skeletal Muscle Wasting: Potential Mechanism of Cachexia in Congestive Heart Failure.: 271 Journal of Investigative Medicine. 55. DOI: 10.1097/00042871-200701010-00785 |
0.433 |
|
| 2007 |
Higashi Y, Sukhanov S, Shai S-, Titterington J, Delafontaine P. 196 Insulin-Like Growth Factor 1 Prevents Atherosclerosis Progression In Aged Apolipoprotein E-Deficient Mice. Journal of Investigative Medicine. 55. DOI: 10.1097/00042871-200701010-00683 |
0.746 |
|
| 2007 |
Higashi Y, Sukhanov S, Parthasarathy S, Delafontaine P. OXIDIZED LOW-DENSITY LIPOPROTEIN DOWN-REGULATES INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR VIA ENHANCED GENERATION OF NITRIC OXIDE AND REACTIVE OXYGEN SPECIES IN HUMAN AORTIC SMOOTH MUSCLE CELLS. Journal of Investigative Medicine. 55: S247. DOI: 10.1097/00042871-200701010-00515 |
0.562 |
|
| 2006 |
Mourkioti F, Kratsios P, Luedde T, Song YH, Delafontaine P, Adami R, Parente V, Bottinelli R, Pasparakis M, Rosenthal N. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. The Journal of Clinical Investigation. 116: 2945-54. PMID 17080195 DOI: 10.1172/Jci28721 |
0.424 |
|
| 2006 |
Sukhanov S, Higashi Y, Shai SY, Itabe H, Ono K, Parthasarathy S, Delafontaine P. Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase. Circulation Research. 99: 191-200. PMID 16778134 DOI: 10.1161/01.Res.0000232319.02303.8C |
0.415 |
|
| 2006 |
Li Y, Song YH, Mohler J, Delafontaine P. ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2116-23. PMID 16339840 DOI: 10.1152/Ajpheart.00551.2005 |
0.439 |
|
| 2005 |
Song YH, Godard M, Li Y, Richmond SR, Rosenthal N, Delafontaine P. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 53: 135-42. PMID 15921033 DOI: 10.2310/6650.2005.00309 |
0.528 |
|
| 2005 |
Higashi Y, Peng T, Du J, Sukhanov S, Li Y, Itabe H, Parthasarathy S, Delafontaine P. A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor. Journal of Lipid Research. 46: 1266-77. PMID 15805544 DOI: 10.1194/Jlr.M400478-Jlr200 |
0.478 |
|
| 2005 |
Sukhanov S, Delafontaine P. Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells. Proteomics. 5: 1274-80. PMID 15732133 DOI: 10.1002/Pmic.200400985 |
0.413 |
|
| 2005 |
Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. The Journal of Clinical Investigation. 115: 451-8. PMID 15650772 DOI: 10.1172/Jci22324 |
0.459 |
|
| 2004 |
Ono K, Sukhanov S, Song YH, Delafontaine P. 1083-191 Biphasic regulation of STAT1 alpha expression in vascular smooth muscle cells by oxidized low-density lipoprotein Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)92025-6 |
0.428 |
|
| 2004 |
Sukhanov S, Ono K, Higashi Y, Delafontaine P. 1064-187 A novel metabolic effect of oxidized low-density lipoprotein: Downregulation of glyceraldehyde-3-phosphate dehydrogenase via a CD36 scavenger receptor-mediated redox pathway involving 5-lipoxygenase Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)91974-2 |
0.333 |
|
| 2004 |
Sukhanov S, Higashi Y, Delafontaine P. 1029-178 Potential involvement of novel scavenger receptor in oxidized low-density lipoproteins promoted atherogenic effects in human aortic smooth muscle cells Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)91924-9 |
0.488 |
|
| 2003 |
Myit S, Delafontaine P, Bochaton-Piallat ML, Giraud S, Gabbiani G, Brink M. Different growth properties of neointimal and medial smooth muscle cells in response to growth factors. Journal of Vascular Research. 40: 97-104. PMID 12808345 DOI: 10.1159/000070706 |
0.492 |
|
| 2003 |
Sukhanov S, Hua Song Y, Delafontaine P. Global analysis of differentially expressed genes in oxidized LDL-treated human aortic smooth muscle cells. Biochemical and Biophysical Research Communications. 306: 443-9. PMID 12804583 |
0.301 |
|
| 2001 |
Du J, Brink M, Peng T, Mottironi B, Delafontaine P. Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway. Circulation Research. 88: 1044-1052. PMID 11375274 DOI: 10.1161/Hh1001.090840 |
0.497 |
|
| 2001 |
Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, Delafontaine P. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology. 142: 1489-96. PMID 11250929 DOI: 10.1210/Endo.142.4.8082 |
0.447 |
|
| 2000 |
Scheidegger KJ, James RW, Delafontaine P. Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. The Journal of Biological Chemistry. 275: 26864-9. PMID 10862615 DOI: 10.1074/Jbc.M002887200 |
0.612 |
|
| 2000 |
Anwar A, Zahid AA, Phillips L, Delafontaine P. Insulin-Like Growth Factor Binding Protein-4 Expression Is Decreased by Angiotensin II and Thrombin in Rat Aortic Vascular Smooth Muscle Cells Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 370-376. PMID 10669632 DOI: 10.1161/01.Atv.20.2.370 |
0.537 |
|
| 1999 |
Brink M, Chrast J, Price SR, Mitch WE, Delafontaine P. Angiotensin II stimulates gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake. Hypertension. 34: 1053-1059. PMID 10567181 DOI: 10.1161/01.Hyp.34.5.1053 |
0.441 |
|
| 1999 |
Du J, Peng T, Scheidegger KJ, Delafontaine P. Angiotensin II Activation of Insulin-Like Growth Factor 1 Receptor Transcription Is Mediated by a Tyrosine Kinase–Dependent Redox-Sensitive Mechanism Arteriosclerosis, Thrombosis, and Vascular Biology. 19: 2119-2126. PMID 10479653 DOI: 10.1161/01.Atv.19.9.2119 |
0.475 |
|
| 1999 |
Scheidegger KJ, Du J, Delafontaine P. Distinct and common pathways in the regulation of insulin-like growth factor-1 receptor gene expression by angiotensin II and basic fibroblast growth factor. The Journal of Biological Chemistry. 274: 3522-30. PMID 9920898 DOI: 10.1074/Jbc.274.6.3522 |
0.476 |
|
| 1997 |
Lou H, Zhao Y, Delafontaine P, Kodama T, Katz N, Ramwell PW, Foegh ML. Estrogen Effects on Insulin-Like Growth Factor-I (IGF-I)–Induced Cell Proliferation and IGF-I Expression in Native and Allograft Vessels Circulation. 96: 927-933. PMID 9264503 DOI: 10.1161/01.Cir.96.3.927 |
0.486 |
|
| 1997 |
Ali MS, Schieffer B, Delafontaine P, Bernstein KE, Ling BN, Marrero MB. Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells Journal of Biological Chemistry. 272: 12373-12379. PMID 9139682 DOI: 10.1074/Jbc.272.19.12373 |
0.462 |
|
| 1997 |
Delafontaine P, Ku L. Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells. Cardiovascular Research. 33: 216-222. PMID 9059547 DOI: 10.1016/S0008-6363(96)00179-4 |
0.532 |
|
| 1996 |
Delafontaine P, Ku L, Anwar A, Hayzer DJ. Insulin-like growth factor 1 binding protein 3 synthesis by aortic endothelial cells is a function of cell density. Biochemical and Biophysical Research Communications. 222: 478-482. PMID 8670230 DOI: 10.1006/Bbrc.1996.0769 |
0.422 |
|
| 1996 |
Du J, Meng XP, Delafontaine P. Transcriptional regulation of the insulin-like growth factor-I receptor gene: evidence for protein kinase C-dependent and -independent pathways. Endocrinology. 137: 1378-1384. PMID 8625914 DOI: 10.1210/Endo.137.4.8625914 |
0.509 |
|
| 1996 |
Cheng HL, Randolph A, Yee D, Delafontaine P, Tennekoon G, Feldman EL. Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. Journal of Neurochemistry. 66: 525-36. PMID 8592122 DOI: 10.1046/J.1471-4159.1996.66020525.X |
0.479 |
|
| 1996 |
Du J, Sperling LS, Marrero MB, Phillips L, Delafontaine P. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochemical and Biophysical Research Communications. 218: 934-9. PMID 8579617 DOI: 10.1006/Bbrc.1996.0165 |
0.498 |
|
| 1996 |
Delafontaine P, Anwar A, Lou H, Ku L. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. Journal of Clinical Investigation. 97: 139-145. PMID 8550825 DOI: 10.1172/Jci118381 |
0.543 |
|
| 1995 |
Delafontaine P, Meng XP, Ku L, Du J. Regulation of vascular smooth muscle cell insulin-like growth factor I receptors by phosphorothioate oligonucleotides. Effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression. The Journal of Biological Chemistry. 270: 14383-8. PMID 7782298 DOI: 10.1074/Jbc.270.24.14383 |
0.556 |
|
| 1995 |
Du J, Delafontaine P. Inhibition of Vascular Smooth Muscle Cell Growth Through Antisense Transcription of a Rat Insulin-Like Growth Factor I Receptor cDNA Circulation Research. 76: 963-972. PMID 7758167 DOI: 10.1161/01.Res.76.6.963 |
0.521 |
|
| 1995 |
Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor Nature. 375: 247-250. PMID 7746328 DOI: 10.1038/375247A0 |
0.366 |
|
| 1995 |
Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system Cardiovascular Research. 30: 825-834. DOI: 10.1016/S0008-6363(95)00163-8 |
0.511 |
|
| 1994 |
Delafontaine P, Ku L, Ververis JJ, Cohen C, Runge MS, Alexander W. Epitope Mapping of the α-Chain of the Insulin-like Growth Factor I Receptor using Antipeptide Antibodies Journal of Molecular and Cellular Cardiology. 26: 1659-1673. PMID 7731060 DOI: 10.1006/Jmcc.1994.1185 |
0.472 |
|
| 1994 |
Anwar A, Delafontaine P. Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta. Hypertension. 24: 679-685. PMID 7527794 DOI: 10.1161/01.Hyp.24.6.679 |
0.478 |
|
| 1994 |
Paxton WG, Marrero MB, Klein JD, Delafontaine P, Berk BC, Bernstein KE. The Angiotensin II AT1 Receptor Is Tyrosine and Serine Phosphorylated and can Serve as a Substrate for the SRC Family of Tyrosine Kinases Biochemical and Biophysical Research Communications. 200: 260-267. PMID 7513159 DOI: 10.1006/Bbrc.1994.1443 |
0.311 |
|
| 1994 |
Ververis J, Ku L, Delafontaine P. Fibroblast Growth Factor Regulates Insulin-like Growth Factor-Binding Protein Production by Vascular Smooth Muscle Cells The American Journal of the Medical Sciences. 307: 77-81. PMID 7511333 DOI: 10.1097/00000441-199402000-00001 |
0.472 |
|
| 1993 |
Ververis JJ, Ku L, Delafontaine P. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circulation Research. 72: 1285-1292. PMID 8495556 DOI: 10.1161/01.Res.72.6.1285 |
0.556 |
|
| 1993 |
Fath KA, Alexander RW, Delafontaine P. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circulation Research. 72: 271-7. PMID 8418983 DOI: 10.1161/01.Res.72.2.271 |
0.519 |
|
| 1993 |
Hanson MC, Fath KA, Alexander RW, Delafontaine P. Induction of cardiac insulin-like growth factor I gene expression in pressure overload hypertrophy. The American Journal of the Medical Sciences. 306: 69-74. PMID 8362894 DOI: 10.1097/00000441-199308000-00001 |
0.453 |
|
| 1993 |
Delafontaine P, Lou H, Harrison DG, Bernstein KE. Sequence of a cDNA encoding dog insulin-like growth factor I Gene. 130: 305-306. PMID 8359700 DOI: 10.1016/0378-1119(93)90437-8 |
0.315 |
|
| 1991 |
Delafontaine P, Lou H, Alexander RW. Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension. 18: 742-747. PMID 1743755 DOI: 10.1161/01.Hyp.18.6.742 |
0.539 |
|
| 1991 |
Delafontaine P, Bernstein KE, Alexander RW. Insulin-like growth factor I gene expression in vascular cells Hypertension. 17: 693-699. PMID 1708744 DOI: 10.1161/01.Hyp.17.5.693 |
0.55 |
|
| 1990 |
Griendling KK, Berk BC, Socorro L, Tsuda T, Delafontaine P, Alexander RW. Secondary signalling mechanisms in angiotensin II-stimulated vascular smooth muscle cells. Clinical and Experimental Pharmacology & Physiology. 15: 105-12. PMID 3078271 DOI: 10.1111/J.1440-1681.1988.Tb01051.X |
0.383 |
|
| Show low-probability matches. |